H

Horizon Pharma (formerly Hyperion Therapeutics)

1000 employees

Hyperion Therapeutics is a biopharmaceutical company focused on creating treatments for urea cycle disorders and other rare diseases.

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology
Health Care
Therapeutics
Biopharma

Date founded

2006

Funding rounds raised

Total raised

$60M

from 10 investors over 10 rounds

H

Horizon Pharma (formerly Hyperion Therapeutics) raised $60M on June 30, 2009

Investors: Panorama Capital, HCP Ltd, Bay City Capital and Sofinnova Ventures, Russia technology fund

H

Horizon Pharma (formerly Hyperion Therapeutics) raised $15M on October 5, 2007

Investors: EQT Life Sciences

H

Horizon Pharma (formerly Hyperion Therapeutics) raised $40M on September 5, 2007

Investors: Washington Research Foundation, Sofinnova Ventures, Russia technology fund and HCP Ltd

H

Horizon Pharma (formerly Hyperion Therapeutics) raised undisclosed on January 5, 2007

Investors: Sofinnova Ventures, Russia technology fund and HCP Ltd

FAQ